J&J Expected To Beat Rivals With Release Of Drug-Coated Stents

03/18/2002 | CNN · Yahoo/Reuters

Johnson & Johnson yesterday unveiled new data that show its antibiotic-coated stent prevents heart arteries from reclogging after 12 months of implantation. The company's Cordis unit is expected to market the device by 2003, six months before its rivals release their solutions. Doctors say the device will help patients needing a repeat procedure.

View Full Article in:

CNN · Yahoo/Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ